ADRB1 and myocardial ischemia: Thus, during local or global cardiac ischemia, the condition will be comparable to that induced by tyramine-stimulation, and inhibition of β1AR-mediated vasodilatation may disturb cardiac perfusion, particularly if combined with losartan, without having the desired effect on cardiac work load and cardiac energy consumption.